483
Patrick Odia, MDFDA 483 - Patrick Odia, MD - February 16, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Patrick Odia, MD in Houston, TX, a clinical investigator site, revealed a significant issue regarding the conduct of an investigation. The primary finding was that the investigator failed to adequately supervise the study, specifically concerning the assessment of subject eligibility by a sub-investigator. This indicates a lack of adherence to the signed statement of investigator and the investigational plan.
Open in Dashboard
ID · 7438a6f8-f162-404c-b3f5-4d50fa6446f7